iPSC-Derived NK Cells and Anti-PD-1 Antibody Synergize to Enhance T Cell Cytokine and Cytolytic Responses Against Multiple Tumors

NK-92 免疫疗法 颗粒酶 免疫学 癌症研究 生物 淋巴因子激活杀伤细胞 肿瘤微环境 白细胞介素21 T细胞 免疫系统 穿孔素 CD8型
作者
Frank Cichocki,Ryan Bjordahl,Svetlana Gaidarova,Sajid Mahmood,Paul Rogers,Moyar Ge,Dan S. Kaufman,Sarah Cooley,Bahram Valamehr,Jeffrey S. Miller
出处
期刊:Blood [American Society of Hematology]
卷期号:132 (Supplement 1): 730-730 被引量:1
标识
DOI:10.1182/blood-2018-99-114893
摘要

Abstract The development of immunotherapeutic monoclonal antibodies targeting checkpoint inhibitory receptors (CIR), such as programmed death 1 (PD-1), has transformed the oncology landscape. However, many tumor subtypes are resistant to CIR-targeted therapy, and relapse remains a significant concern. Therefore, combination of novel immunotherapies with CIR targeting remains a promising and widely investigated approach to bolster anti-tumor responses and to overcome tumor resistance to CIR therapy. Natural killer (NK) cells mediate direct tumor cell lysis and are key regulators of T cell responses through the production of inflammatory cytokines and chemokines. In many cancers, NK cell numbers are low and their functional responses are sub-optimal. The use of allogeneic NK cell immunotherapy has shown significant clinical promise for the treatment of acute myelogenous leukemia (AML). However, this approach has inherent limitations with respect to the number of NK cells that can be isolated and variability in the quantity and quality of NK cells between donors. To overcome these barriers, we have developed a system for large scale expansion of NK cells derived from induced pluripotent stem cells (iPSCs) to be combined with CIR antibodies for multiple tumor types (Figure 1A). iPSC derive NK (iNK) cells (defined as CD45+CD3-CD56+) differentiated with high efficiency in this culture system (Figure 1B), and overall expansion from the hematopoietic progenitor stage to end of the protocol was approximately 1 million-fold (Figure 1C). iNK cells displayed a cell surface phenotype typical of primary peripheral blood NK cells, with high expression of the cytotoxicity molecules granzyme B and perforin. Functionally, iNK cells degranulated and produced the pro-inflammatory cytokines tumor necrosis factor (TNF) and interferon (IFN)-γ at high frequencies in response to K562 cells (a myeloid leukemia cell line) (Figure 1D). These cells also effectively killed a broad range of solid tumor targets, including ovarian cancer (SKOV-3), lung cancer (A549) and pancreatic cancer (PANC-1) cell lines, in 2D tissue culture assays (Figure 1E). To interrogate the ability of iPSC-derived NK cells to synergize with CIR therapy, we used an in vitro 3D tumor spheroid system to model the combinatorial effects of T cells, iNK cells, and checkpoint blockade in the context of anti-tumor function. Using SKOV-3 spheroids as targets in a 160-hour killing assay, we found that iNK cells could mediate significant, but not complete destruction of tumor spheroids (46% tumor reduction). Addition of twice as many activated T cells by themselves induced tumor spheroid destruction (58% tumor reduction). The combination of iNK and activated T cells led to robust target cell destruction (71% tumor reduction). Importantly, the combination of activated T cells, iNK cells and anti-PD-1 antibody led to a near complete elimination of tumor spheroid targets, with greater than 99% tumor reduction (Figure 1F). In addition to synergistic lysis of tumor spheroids, analyses of cytokine secretion in iNK, activated T cell and CIR spheroid cultures revealed synergistic production of TNF and IFN-g (Figure 1G). The results from our 3D spheroid assays led us to hypothesize that iNK cells could recruit T cells to promote tumor lysis. To test this hypothesis, we performed transwell migration assays to test the relative abilities of iNK cells and K562 cells to promote T cell migration. We found that, relative to media controls, both iNK cells and K562 cells promoted T cell migration across transwells, and the highest amount of degree of migration was observed in the presence of both iNK and K562 cells (Figure 1H). Finally, we tested iNK-mediated T cell recruitment in an in vivo setting where iNK cells and IL-2 were injected with or without K562 cells into the peritoneal cavities of immune-deficient NSG mice, and activated T cells were injected retro-orbitally into the blood. Mice were sacrificed 4 days later, and total T cells in the peritoneal cavities were determined. Compared to the T cell only control group, iNK cells promoted significant T cell recruitment to the peritoneum, which was amplified upon iNK cell activation with the addition of K562 cells (Figure 1I). Together, our data demonstrate that iNK cells can serve as an off-the-shelf source of NK cells and have the potential to synergize with anti-PD-1 CIR therapy to enhance anti-tumor T cell responses. Disclosures Cichocki: Fate Therapeutics Inc.: Consultancy, Research Funding. Bjordahl:Fate Therapeutics Inc.: Employment. Gaidarova:Fate Therapeutics Inc: Employment. Mahmood:Fate Therapeutics Inc.: Employment. Rogers:Fate Therapeutics Inc: Employment. Ge:Fate Therapeutics Inc.: Employment. Kaufman:Fate Therapeutics: Consultancy, Research Funding. Valamehr:Fate Therapeutics Inc.: Employment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
瘦瘦马里奥完成签到,获得积分10
3秒前
LXZ完成签到,获得积分10
6秒前
韧迹完成签到 ,获得积分10
6秒前
超体完成签到 ,获得积分10
9秒前
zhangh65完成签到,获得积分10
9秒前
自由的无色完成签到 ,获得积分10
9秒前
xiaofeng5838完成签到,获得积分10
10秒前
雪白的紫翠完成签到 ,获得积分10
11秒前
白白不焦虑完成签到,获得积分10
12秒前
艾欧比完成签到 ,获得积分10
14秒前
丘比特应助Jaja采纳,获得10
15秒前
研友_VZG7GZ应助吱吱采纳,获得10
21秒前
聪明小丸子完成签到,获得积分10
22秒前
kingkingwang2013完成签到,获得积分20
22秒前
Barbarian完成签到,获得积分10
26秒前
善学以致用应助黑球采纳,获得10
40秒前
9239完成签到 ,获得积分10
41秒前
幼荷完成签到 ,获得积分10
41秒前
沉默的婴完成签到 ,获得积分10
42秒前
辞清完成签到 ,获得积分10
45秒前
科研通AI2S应助jxas采纳,获得10
48秒前
处处吻完成签到 ,获得积分10
53秒前
MADAO完成签到 ,获得积分10
54秒前
Avicii完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
Jaja发布了新的文献求助10
1分钟前
友好亚男完成签到 ,获得积分10
1分钟前
吱吱发布了新的文献求助10
1分钟前
认真搞科研啦完成签到,获得积分10
1分钟前
哈哈完成签到 ,获得积分10
1分钟前
chhzz完成签到 ,获得积分10
1分钟前
电子屎壳郎完成签到,获得积分10
1分钟前
彭于晏应助吱吱采纳,获得10
1分钟前
青菜虫子完成签到 ,获得积分10
1分钟前
QCB完成签到 ,获得积分10
1分钟前
快乐太英完成签到 ,获得积分10
1分钟前
MEMSforever完成签到,获得积分20
1分钟前
xiaofenzi完成签到,获得积分10
1分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709891
关于积分的说明 7418319
捐赠科研通 2354494
什么是DOI,文献DOI怎么找? 1246122
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921